Your gateway to the European Medical Cannabis market
Since 2020, Medicane’s EU-GMP facility offers contract manufacturing services to cultivators from around the world.
Our dedicated team of professionals with many years of experience in the cannabis industry and our collaboration with world-renowned scientists and prestigious research institutions, has enabled us to create a process where quality and consistency are always the outcome.
We offer services to transform flower grown under GACP guidelines into API and finished product.
Our facility offers the following services:
- Packaging & Labelling
- Certified packaging and labelling tailored to you.
- Bio Burden Waste Reduction
- We can employ an in-house, non-invasive microbial reduction process without the use of irradiation.
- Stability Studies
- Stability studies performed within our facility in accordance with ICH guidelines.
- Internal & External EU-GMP Lab Testing
- Our in-house lab and close partnerships with external GMP certified labs deliver results quickly, reliably, and consistently.
MediCane seed-to-costumer business model allows comprehensive monitoring and control of the cultivation process, along with subsequent medical and pharmaceutical R&D. This model includes genetic seed development, plant propagation, and cultivation, manufacturing, pharmacological development, medical research, and distribution of the final products to end-users.
Our genetic bank contains verity of strains that are organically cultivated in our state-of-the-art greenhouses and then processed in post-harvest and manufacturing facilities under ISO 9001, GAP and GMP quality standards. The distribution of the final products to end-users is carried out through a global BTB and BTC partner network.
By carefully controlling the value chain of medicinal cannabis MediCane aims to deliver APIs of the highest pharma-grade quality. Our genetic bank contains over 100 strains that are organically cultivated in our state-of-the-art greenhouses and then processed in post-harvest and manufacturing facilities under ISO 9001, GAP and GMP quality standards. The distribution of the final products to end-users is carried out through a global BTB and BTC partner network.
MCFC Medical Chemical-Free Cannabis
MCFC (Medical Chemical-Free Cannabis) is a joint venture of MediCane and Yissum, a technology transfer company of the Hebrew University of Jerusalem
MCFC was established with the aim to eliminate the use of chemical insecticides by employing patented RF technology. It is a cost-effective, non-toxic and versatile solution that replaces the use of dangerous pesticides, making organic cannabis products safer.
MediCane holds the exclusive right to distribute the Canna-Wave device, a patented hardware and software electronic system based on proven Radio Frequency (RF) which ensures the cannabis greenhouses is 100% insecticide and insect free. With Canna-Wave we quickly, safely and cost effectively hinder insect infestations in our greenhouses without the use of dangerous insecticides.